drugset / Trial / NCT03582488
Longitudinal Imaging Biomarkers of Disease Progression in DLB
Phase 4
Enrolling by invitation
135 enrolled
Kejal Kantarci
National Institute of Neurological Disorders and Stroke (NINDS) · collab
NaSingle-groupOpen-labelDiagnostic
Summary
The Researchers are trying to determine the paths of change in imaging biomarkers of Dementia with Lewy bodies (DLB) and their associations with rate of cognitive and functional decline.
Timeline
- Start
- 2018-06-25
- Primary completion
- 2027-09
- Completion
- 2027-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Flortaucipir F18 | Diagnostic / imaging agent | — | — |